As of Nov 25
| +0.14 / +2.32%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 20.00 and a low estimate of 9.50. The median estimate represents a +94.49% increase from the last price of 6.17.
The current consensus among 5 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.